卢旺达妇女接触武装冲突和艾滋病毒风险
Kammi K Schmeer1, Paola Andrea Echave2, Hollie Nyseth Nzitatira1
1Department of Sociology, The Ohio State University, Columbus, OH, USA.
Demography
|July 25, 2023
概括
在青春期末暴露于卢旺达种族灭绝,显著增加了女性长期感染艾滋病毒的风险. 在生命的关键阶段经历激烈的冲突和兄弟姐妹的丧失会影响女性的性健康结果.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 社会学 社会学 社会学
背景情况:
- 撒哈拉以南非洲地区面临着一个关键的公共卫生挑战,即在生育年龄的妇女中艾滋病毒阳性状态.
- 过去接触暴力越来越被认为是影响健康结果的重要因素.
研究的目的:
- 评估暴露于卢旺达战争和种族灭绝 (1990-1994) 的时间和强度与生育年龄妇女的艾滋病毒阳性状况之间的关联.
- 研究在不同生命阶段经历武装冲突如何影响长期性健康.
主要方法:
- 利用了卢旺达人口和健康调查 (2005-2014) 的生物社会数据.
- 分析了暴露在冲突中的年龄的影响,并报告了冲突期间兄弟姐妹死亡的艾滋病毒状况.
- 根据当前的社会经济和人口特征进行控制.
主要成果:
- 在青春晚期 (1970-1974年出生的) 暴露的妇女在冲突后10-20年显示出患艾滋病毒的风险最高.
- 在冲突期间报告两名或更多兄弟姐妹的死亡与艾滋病毒阳性状况的更高几率有关.
- 第一次性交的年龄和性伴侣的数量部分解释了这些关联,但没有完全解释它们.
结论:
- 在关键的人生阶段和更强烈的武装冲突中经历武装冲突可能会对女性的长期性健康产生负面影响.
- 调查结果强调了冲突暴露对撒哈拉以南非洲妇女艾滋病毒风险的持久公共卫生后果.
更多相关视频
相关概念视频
Sexually Transmitted Infections
352
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
352
Factors Affecting the Risk of Infection
12.0K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.0K
Relative Risk
222
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
222
Pulmonary Tuberculosis I
269
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
269
Cross-reactivity
31.3K
Overview
31.3K
Hazard Ratio
160
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
160


